Open Access

The role of helium gas in medicine

Medical Gas Research20133:18

DOI: 10.1186/2045-9912-3-18

Received: 12 June 2013

Accepted: 25 July 2013

Published: 4 August 2013

Abstract

The noble gas helium has many applications owing to its distinct physical and chemical characteristics, namely: its low density, low solubility, and high thermal conductivity. Chiefly, the abundance of studies in medicine relating to helium are concentrated in its possibility of being used as an adjunct therapy in a number of respiratory ailments such as asthma exacerbation, COPD, ARDS, croup, and bronchiolitis. Helium gas, once believed to be biologically inert, has been recently shown to be beneficial in protecting the myocardium from ischemia by various mechanisms. Though neuroprotection of brain tissue has been documented, the mechanism by which it does so has yet to be made clear. Surgeons are exploring using helium instead of carbon dioxide to insufflate the abdomen of patients undergoing laparoscopic abdominal procedures due to its superiority in preventing respiratory acidosis in patients with comorbid conditions that cause carbon dioxide retention. Newly discovered applications in Pulmonary MRI radiology and imaging of organs in very fine detail using Helium Ion Microscopy has opened exciting new possibilities for the use of helium gas in technologically advanced fields of medicine.

Keywords

Helium Heliox Inhalation therapy Cardioprotection Neuroprotection Insufflation

Introduction

Helium is a very light, odorless, tasteless, and colorless noble gas with a strong safety profile and multiple applications. It does not support combustion. It is unique in that the boiling point −452.1°F (−268.9°C) and melting points −458°F (−272.2°C) are the lowest among the elements. Helium is the second most abundant element in the universe. Despite this, most of the helium in use is a byproduct of radioactive decay underground and must be extracted during natural gas production. Helium is used for purposes that require some of its unique properties: its low density, low solubility, and high thermal conductivity. 7,000 tons, or 22%, of the total helium used involves the cooling of superconducting magnets in medical magnetic resonance imaging (MRI) scanners. Though commonly known as a lifting gas in balloons and airships, this use accounts for less than 7% of the total used [1].

Helium is the lightest noble gas (4 g/mol). The only gas with a lower density than helium is hydrogen [2]. The use of hydrogen is more limited than helium because of its flammability in air mixtures. Helium (0.179 g/L) is 86% less dense than room air (1.293 g/L) and 8 times less dense than oxygen (1.429 g/L) (Figure 1). This unique property has been critical to its multiple applications.
https://static-content.springer.com/image/art%3A10.1186%2F2045-9912-3-18/MediaObjects/13618_2013_Article_79_Fig1_HTML.jpg
Figure 1

The density of helium is substantially lower than other gases, accounting for its multiple applications in respiratory therapy.

The high thermal conductivity of helium results in lower body temperature when the body is embedded in helium, which could result in decreased metabolism and decreased energy expenditure [3]. Hypothermia was induced in rats breathing 75% helium for extended periods [4]. In humans, breathing helium for short periods has not been shown to induce hypothermia [5].

History of helium as a therapeutic gas

In 1926, Sayers and Yant found that helium-oxygen mixtures could be breathed by humans without discomfort, and by animals without demonstrable ill effects. Due to the lower solubility of helium compared with nitrogen, using a mixture of helium and oxygen (Heliox) rather than nitrogen and oxygen decreased the formation of nitrogen bubbles and therefore decompression illness in deep-sea divers [6].

In 1934, Barach was first to propose using Heliox as a therapeutic gas [7]. Since a helium/oxygen mixture (79/21) has a weight that is one-third compared with air, Barach proposed using this lighter gas to improve the flow of oxygen in patients with upper airway obstruction and asthma exacerbation [810].

Interest in the clinical use of helium declined temporarily after this period of time due to the advent of bronchodilators and mucolytic agents and also because of the loss of sources of helium production during the Second World War [11]. In the 1980s, interest in helium gas research resurfaced as the number of asthma related deaths began to rise [12]. Within the last 10 years, there has been an increased interest in studies involving the use of Helium (Figure 2).
https://static-content.springer.com/image/art%3A10.1186%2F2045-9912-3-18/MediaObjects/13618_2013_Article_79_Fig2_HTML.jpg
Figure 2

A search of PubMed for articles titled helium shows an increased number of publications with an interest in helium within the last 10 years. A PubMed search was performed with helium contained in the text of the title and the search results were counted and graphed by year.

Unlike the noble gas xenon, helium does not have anesthetic properties [13]. Given in higher pressures predicted to be anesthetic by the Meyer-Overton hypothesis, helium actually increases the minimum alveolar concentration for volatile anesthetics and also is shown to produce convulsions. Helium is therefore characterized as a non-immobilizer, a gas that does not induce anesthesia, but may still have other biological effects [14].

Effects of helium on different organs

Helium and the respiratory system

The flow of a gas depends on the density and viscosity of each element within a gas mixture. The low density of helium reduces airway resistance and promotes airflow through the lungs. Heliox decreases the work of breathing (WOB) in patients with increased airway resistance [15]. Therefore heliox has been reported to be effective in a variety of respiratory conditions including upper airway obstruction, asthma exacerbation, post-extubation stridor, croup, bronchiolitis, chronic obstructive pulmonary disease (COPD), acute respiratory distress syndrome (ARDS), and pulmonary function testing [1621]. In a rat model simulating ARDS, heliox was effective in decreasing neutrophil infiltration, interstitial/intraalveolar edema, perivascular and/or intraalveolar hemorrhage, and hyaline membrane formation histopathologically [22].

In 1938 Sykes and Lawrence found that an artificial atmosphere of helium and oxygen is practically about twice as easy to breathe as ordinary air [23]. In stable asthmatics, is has been shown that Heliox led to more effective deposition of radiolabeled particles in the lung [24]. During severe acute asthma exacerbations, it has been found that albuterol nebulized with Heliox leads to a more significant improvement in spirometry when compared with albuterol nebulized with oxygen, because the low-density gas improves albuterol deposition in the distal airways (Figure 3) [25]. In infants with moderate-to-severe respiratory syncytial virus (RSV) bronchiolitis, Heliox therapy improved their clinical scores and reduced accompanying tachycardia and tachypnea [26]. Heliox also improves the elimination of CO2. Compared with a mixture of N2/O2, CO2 diffuses four to five times faster in Heliox. This property significantly reduces hypercapnia and normalizes pH [27].
https://static-content.springer.com/image/art%3A10.1186%2F2045-9912-3-18/MediaObjects/13618_2013_Article_79_Fig3_HTML.jpg
Figure 3

Because of the very low density of helium, there is better delivery of albuterol nebulized with helium (Left) compared with albuterol nebulized with oxygen (Right) in the lungs.

Breathing Heliox increases the duration of exercise training that can be performed in patients with chronic obstructive pulmonary disease (COPD), augmenting the known benefits of a comprehensive pulmonary rehabilitation program [28]. In acute status asthmaticus in children, inhalational Heliox therapy significantly improved pulsus paradoxus, peak flow, and dyspnea. Heliox also reduced the work of breathing in children, with the potential to prevent respiratory muscle fatigue and ventilatory failure [29].

Helium and the cardiovascular system

It has been shown that myocardial tissue can be protected against ischemia by subjecting it to one or a few short ischemic episodes before ischemia. Early preconditioning (EPC) or late preconditioning (LPC) before ischemia or post-conditioning (Post C) after myocardial ischemia, ameliorates myocardial ischemia [30]. In a study on myocardial infarct size in rabbits, three 5-minute cycles of 70% helium, neon, and argon modestly reduced myocardial infarct size [31].

It has also been shown that helium inhalation enhances vasodilator effect of inhaled nitric oxide on pulmonary vessels in hypoxic dogs. Compared with nitric oxide (NO) in nitrogen gas (N2), the mean pulmonary artery pressure decreased significantly after NO inhalation in helium, indicating a greater vasodilator effect of NO in helium. It is likely that NO delivery to the periphery of the lungs was facilitated by helium more than by N2[32].

In a study of 17 healthy men subjected to 15 minutes of submaximal exercise on an Elema-Schonander cycle ergometer while breathing ambient air or Heliox, it was shown that Heliox improved exercise tolerance while reducing rising lactate and pyruvate levels compared with ambient air [33].

Helium has been demonstrated to protect myocardial tissue from ischemia by various different mechanisms. Pagel et. al performed a left-anterior descending (LAD) coronary artery occlusion in rabbits and found that animals treated with a helium gas mixture had significantly reduced infarct size compared with control groups. They found that the cardioprotection was due to the activation of pro-survival signaling kinases and the inhibition of mitochondrial permeability transition pore (mPTP) opening [31]. Later, they found that Helium maintains intracellular acidosis during early reperfusion, which inhibits mitochondrial transition pore formation [34]. In subsequent studies, researchers found that reactive oxygen species (including nitric oxide) [35, 36], mitochondrial adenosine triphosphate-regulated potassium channels, [37], and opioid receptors [38] were responsible for the cardio-protective effects induced by helium preconditioning.

Heinen et. al applied Heliox as a pre-conditioning modality in a rat heart ischemia and reperfusion model. The results revealed that the cardio-protective effects of Heliox pre-conditioning in young rats were due to two additional mechanisms: mitochondrial uncoupling and Ca2+ sensitive potassium channel activation [39].

Helium protects healthy myocardium against ischemia & reperfusion injury by early and late preconditioning (EPC,LPC) and postconditioning (PostC). In 2012, Weber et. al found that triple intervention of EPC, LPC, and PostC significantly reduced infarct sizes in spontaneously hypertensive rats [40].

Application of helium in neurology

The lighter inert gases neon and helium are not anesthetics at least up to the highest pressures that can be tolerated before the confounding effects of high-pressure neurological syndrome become pronounced [14, 41]. At these high pressures (~ 100 atm), the manifestations of high-pressure nervous syndrome include hyper excitability, tremors, and convulsions which would act to oppose any sedative or anesthetic effect [42, 43].

Evidence that xenon has neuroprotective properties has prompted researchers to explore whether or not other inert gases have this potential. Only a few studies have investigated the effects of Heliox treatment or pre-conditioning in the nervous system, and the mechanism has yet to be properly elucidated. Pan et. al compared the difference in treatment with hyperoxia and Heliox during the ischemia &reperfusion process in the brain [44]. They found that Heliox was superior to hyperoxia in both in infarct volume reductions and improvements in neurological deficits.

In a similar study, Coburn et. al found that in an in vitro model of traumatic brain injury, treatment with helium at elevated pressures had neuroprotective effects [45]. In a different in vitro study of cultured neurons however, Rivzi et. al reported that normobaric helium was detrimental to neuron survival after hypoxia [46], and human tubular kidney cells [47]. The reason for the differing results has not been made clear.

In another study, rats treated with Helium below body temperature subjected to middle cerebral artery occlusion (MCAO) had decreased infarct size and improved neurological outcome. In rats treated with Helium at 33°C, the neuroprotective effect of Helium was abolished. The authors contributed the beneficial effect of helium to hypothermia caused by the high thermal conductivity of helium compared with air [4]. While many pharmacological targets have been discovered for xenon, no targets have yet been discovered for helium, [48] opening up many future investigational opportunities.

Remarkably, an in vitro study of Schwann cells isolated from sciatic nerves of 4–5 day old rats; researchers found that irradiating the cells with a Helium-neon laser caused proliferation of the cells in a dose dependent manner [49]. This application is promising in regards to neuron restoration post injury.

Helium gas in surgery

In 2003, Brackman et. al found that helium pneumoperitoneum ameliorates hypercarbia and acidosis associated with carbon dioxide insufflation during laparoscopic gastric bypass in pigs [50].

Laparoscopic surgery is now a widely performed in treating various abdominal diseases. The procedure requires distending the abdomen via insufflation with carbon dioxide gas to visualize abdominal structures and provide space for the manipulation of medical instruments. Carbon dioxide is absorbed by the peritoneum and alters physiologic parameters, which can complicate surgery: mainly changes to the heart and lungs (cardiopulmonary changes). Cheng et. al performed a meta-analysis of all the studies using other medical gases, nitrous oxide and helium, in creating the pneumoperitoneum required for performing abdominal laparoscopic surgery. Their results concluded that there were fewer cardiopulmonary changes with helium than with carbon dioxide [51].

Helium has been found to be a safe alternative as an insufflant in high-risk patients undergoing laparoscopic renal surgery. Researchers cite that patients who benefit most are those with difficulty in clearing CO2 gas from their bloodstream, such as patients with comorbid conditions like COPD, congestive heart failure, chronic hypoxia from an intrapulmonary shunt, malignant hyperthermia, and chronic hypoxia from multiple pulmonary infarcts [52]. In general surgery, helium is being explored as a promising abdominal insufflant alternative to CO2 because in laboratory and clinical trials, helium has not produced the respiratory acidosis commonly associated with insufflation using CO2[53]. Furthermore, Waseda et. al found that helium pneumoperitoneum could improve the recovery of postoperative gastrointestinal motility because of the reduction of hypercapnia and acidosis compared with CO2 pneumoperitoneum [54].

Helium plasma technology has also found an application in abdominal and laparoscopic surgery. Helium plasma is being used in the thermal coagulation of tissues that clears the bleeding from the surgical field and enhances visualization of bleeding sites [55].

The future of helium research

Since the discovery of helium, the applications of helium have evolved greatly. Current research shows that helium gas is being studied in cutting edge technologically advanced medical fields such radiology and microscopy.

Helium in radiology

Because of inherently low 1H abundance in the lungs, MRI of the lungs has been more challenging to adequately visualize than other body tissues. Furthermore, air-tissue interfaces in the lung create magnetic field distortions, which further diminishes the lung magnetic resonance 1H signal. Respiratory and cardiac motion further deteriorates pulmonary MRI quality [56].

Inhaled, hyperpolarized helium (HP 3He) overcomes the low proton density in both normal and diseased lungs. Polarization of largely achieved using the spin exchange optical pumping method (SEOP) [5759]. The nuclear polarization of the unpaired nuclear proton increases up to five orders of magnitude compared to a modest linear increase with field strength using thermal polarization [6062]. The application of hyperpolarized Xenon (HP 129Xe) MRI has lagged behind HP 3He MRI methods mostly because 129Xenon is more challenging to polarize [59].

Using the SEOP method, the helium gas is polarized overnight (12–14 hours) and inhaled by subjects from a bag mixed with medical nitrogen for immediate breath-hold imaging (8–16 sec). The method is safe, requires no ionizing radiation dose, and can be repeatedly inhaled facilitating longitudinal [63, 64], interventional [65], and pediatric exams [66]. HP 3He MRI can provide additional information regarding lung oxygenation that was not possible with traditional high-resolution computed tomography (HRCT) or MRI.

Helium in microscopy

Helium ion scanning microscopy (HIM) is a novel imaging technology with the capability of providing sub-nanometer resolution images of uncoated biologic tissues. Taking advantage of helium ion microscopy, Rice et. al were able to explore the epithelium of the rat kidney with unsurpassed image quality and detail [67]. With the helium ion system, fine details such as membrane texture and membranous nanoprojections on glomerular podocytes were visualized.

Conclusion

In conclusion, the many applications of helium gas in medicine are due to its unique physical and chemical properties including its low solubility, high thermal conductivity, and low density. Helium has been most studied as a possible adjunct to respiratory therapy. Studies investigating helium gas regarding protection of the myocardium after ischemia has elucidated many mechanisms for a gas once thought to be biologically inert. With regards to neuroprotection, more studies are required to elucidate the neuroprotective mechanism that Helium gas has on neurons and to resolve some controversies in the literature. In general surgery, applying helium during laparoscopic surgery has beneficial effects not offered traditionally by carbon dioxide. Helium has exciting new applications in medicine with regards to MRI imaging of the lungs, and microscopic imaging (Figure 4).
https://static-content.springer.com/image/art%3A10.1186%2F2045-9912-3-18/MediaObjects/13618_2013_Article_79_Fig4_HTML.jpg
Figure 4

A summary of the many known effects and applications of helium gas in medicine.

Abbreviations

ARDS: 

Acute respiratory distress syndrome

COPD: 

Chronic obstructive pulmonary disease

EPC: 

Early preconditioning

Heliox: 

Helium-oxygen

HIM: 

Helium ion microscopy

HP 3He: 

Hyperpolarized helium

HP 129Xe: 

Hyperpolarized xenon

LAD: 

Left anterior descending

LPC: 

Late preconditioning

MCAO: 

Middle cerebral artery occlusion

MRI: 

Magnetic resonance imaging

PostC: 

Post-conditioning

RSV: 

Respiratory syncytial virus

SEOP: 

Spin exchange optical pumping

WOB: 

Work of breathing.

Declarations

Authors’ Affiliations

(1)
Departments of Neurosurgery and Physiology, Loma Linda University

References

  1. Banks M: PhysicsWorld.com. Helium Sell-off Risks Future Supply. 2010, Institute of Physics, Web. 1 Jan. 2012Google Scholar
  2. Harris PD, Barnes R: The uses of helium and xenon in current clinical practice. Anesthesia. 2008, 63: 284-293. 10.1111/j.1365-2044.2007.05253.x.View ArticleGoogle Scholar
  3. Singer D: Why 37 degrees C? Evolutionary fundamentals of thermoregulation. Anesthetist. 2007, 56: 899-906. 10.1007/s00101-007-1220-y.View ArticleGoogle Scholar
  4. David HN, Haelewyn B, Chazalviel L, Lecocq M, Degoulet M, Risso JJ, Abraini JH: Post- ischemic helium provides Neuroprotection in rats subjected to middle cerebral artery occlusion-induced ischemia by producing hypothermia. J Cereb Blood Flow Metab. 2009, 29: 1159-65.8-12-View ArticleGoogle Scholar
  5. Hess DR, Fink JB, Venkataraman ST, Kim IK, Myers TR, Tano BD: The history and physics of Heliox. Respir Care. 2006, 51 (6): 608-612.PubMedGoogle Scholar
  6. Sayers RR, Yant WP: The Value of Helium-Oxygen Atmosphere in Diving and Caisson Operations. Anesth Analg. 1926, 5 (3): 127-138.Google Scholar
  7. Barach AL: Use of helium as a new therapeutic gas. Proc Soc Exper Biol and Med. 1934, 32: 462-464. 10.3181/00379727-32-7724P.View ArticleGoogle Scholar
  8. Barach AL: Therapeutic use of helium. JAMA. 1935, 107: 1273-1280.View ArticleGoogle Scholar
  9. Barach AL: The use of Helium in the treatment of Asthma and Obstructive lesions in the larynx and trachea. Ann Intern Med. 1935, 9 (6): 739-765.View ArticleGoogle Scholar
  10. Barach AL: The Effects of Inhalation of Helium Mixed with Oxygen on the Mechanics of Respiration. J Clin Invest. 1936, 15 (1): 47-61. 10.1172/JCI100758.PubMed CentralPubMedView ArticleGoogle Scholar
  11. Reuben AD, Harris AR: Heliox for asthma in the emergency department: a review of the literature. Emerg Med J. 2004, 21: 131-135. 10.1136/emj.2002.003483.PubMed CentralPubMedView ArticleGoogle Scholar
  12. Rodrigo GJ, Pollack CV, Rodrigo C, Rowe BH: Heliox for non-intubated acute asthma patients. Cochrane Database Syst Rev. 2006, No (4): CD002884-10.1002/14651858.CD002884.pub2.Google Scholar
  13. Hausenloy DJ, Yellon DM: Preconditioning and postconditioning: Underlying mechanisms and clinical application. Atherosclerosis. 2009, 204 (2): 334-341. 10.1016/j.atherosclerosis.2008.10.029.PubMedView ArticleGoogle Scholar
  14. Koblin DD, Fang Z, Eger EI, Laster MJ, Gong D, Ionescu P, Halsey MJ, Trudell JR: Minimum alveolar concentrations of noble gases, nitrogen, and sulfur hexafluoride in rats: Helium and neon as nonimmobilizers (nonanesthetics). Anesth Analg. 1998, 87: 419-424.PubMedGoogle Scholar
  15. Barnett TB: Effects of helium and oxygen mixtures on pulmonary mechanics during airway constriction. J Appl Physiol. 1967, 22: 707-713.PubMedGoogle Scholar
  16. Barnett TB: Effects of helium and oxygen mixtures on pulmonary mechanics during airway constriction. J Appl Physiol. 1967, 22 (4): 707-713.PubMedGoogle Scholar
  17. Gupta VK, Cheifetz IM: Heliox administration in the pediatric intensive care unit: an evidence-based review. Pediatr Crit Care Med. 2005, 6 (2): 204-211. 10.1097/01.PCC.0000154946.62733.94.PubMedView ArticleGoogle Scholar
  18. Kemper KJ, Ritz RH, Benson MS, Bishop MS: Helium-oxygen mixture in the treatment of postextubation stridor in pediatric trauma patients. Crit Care Med. 1991, 19 (3): 356-359. 10.1097/00003246-199103000-00013.PubMedView ArticleGoogle Scholar
  19. Gluck EH, Onoranto DJ, Castriotta R: Helium-oxygen mixtures in intubated patients with status asthmaticus and respiratory acidosis. Chest. 1990, 98 (3): 693-698. 10.1378/chest.98.3.693.PubMedView ArticleGoogle Scholar
  20. Rodeberg DA, Easter AJ, Washam MA, Housinger TA, Greenhalgh DG, Warden GD: Use of a helium-oxygen mixture in the treatment of postextubation stridor in pediatric patients with burns. J Burn Care Rehab. 1995, 16 (5): 476-480. 10.1097/00004630-199509000-00003.View ArticleGoogle Scholar
  21. Anderson M, Svartengren M, Bylin G, Philipson K, Camner P: Deposition in asthmatics of particles inhaled in air or in helium-oxygen. Am Rev Respir Dis. 1993, 147 (3): 524-528. 10.1164/ajrccm/147.3.524.PubMedView ArticleGoogle Scholar
  22. Sema Y, Kenan D, Dincer Y, Ibrahim B, Derya G, Sait P: The effectiveness of Heliox in acute respiratory distress syndrome. Ann Thorac Med. 2013, 8 (1): 46-52. 10.4103/1817-1737.105719.View ArticleGoogle Scholar
  23. Sykes WS, Lawrence RC: Helium in Anesthesia. Br Med J. 1938, 2 (4051): 448-449. 10.1136/bmj.2.4051.448.PubMed CentralPubMedView ArticleGoogle Scholar
  24. Anderson M, Svartengren M, Bylin G, Philipson K, Camner P: Deposition in asthmatics of particles inhaled in air or in helium-oxygen. Am Rev Respir Dis. 1993, 147: 524-528. 10.1164/ajrccm/147.3.524.PubMedView ArticleGoogle Scholar
  25. Kress JP, Noth I, Gehlbach BK, Barman N, Pohlman AS, Miller A, Morgan S, Hall JB: The utility of albuterol nebulized with Heliox during acute asthma exacerbations. Am J Respir Crit Care Med. 2002, 165 (9): 1317-1321. 10.1164/rccm.9907035.PubMedView ArticleGoogle Scholar
  26. Martinón-Torres F, Rodríguez-Núñez A, Martinón-Sánchez JM: Heliox therapy in infants with acute bronchiolitis. Pediatrics. 2002, 109 (1): 68-73. 10.1542/peds.109.1.68.PubMedView ArticleGoogle Scholar
  27. Debiński W, Kłossowski M, Gembicka D: Effect of breathing of a helium oxygen mixture on the adaptation of the organism to exercise. Acta Physiol Pol. 1984, 35 (3): 285-292.PubMedGoogle Scholar
  28. Eves ND, Sandmeyer LC, Wong EY, Jones LW, MacDonald GF, Ford GT, Petersen SR, Bibeau MD, Jones RL: Helium-hyperoxia: a novel intervention to improve the benefits of pulmonary rehabilitation for patients with COPD. Chest. 2009, 135 (3): 609-618. 10.1378/chest.08-1517.PubMedView ArticleGoogle Scholar
  29. Kudukis TM, Manthous CA, Schmidt GA, Hall JB, Wylam ME: Inhaled helium oxygen revisited: effect of inhaled helium-oxygen during the treatment of status asthmaticus in children. J Pediatr. 1997, 130 (2): 217-224. 10.1016/S0022-3476(97)70346-9.PubMedView ArticleGoogle Scholar
  30. Hausenloy DJ, Yellon DM: Preconditioning and postconditioning: Underlying mechanisms and clinical application. Atherosclerosis. 2009, 204: 334-341. 10.1016/j.atherosclerosis.2008.10.029.PubMedView ArticleGoogle Scholar
  31. Pagel PS, Krolikowski JG, Shim YH, Venkatapuram S, Kersten JR, Weihrauch D, Warltier DC, Pratt PFJ: Noble gases without anesthetic properties protect myocardium against infarction by activating prosurvival signaling kinases and inhibiting mitochondrial permeability transition in vivo. Anesth Analg. 2007, 105: 562-569. 10.1213/01.ane.0000278083.31991.36.PubMedView ArticleGoogle Scholar
  32. Nie M, Kobayashi H, Sugawara M, Tomita T, Ohara K, Yoshimura H: Helium inhalation enhances vasodilator effect of inhaled nitric oxide on pulmonary vessels in hypoxic dogs. Am J Physiol Heart Circ Physiol. 2001, 280 (4): H1875-H1881.PubMedGoogle Scholar
  33. Debiński W, Kłossowski M, Gembicka D: Effect of breathing of a helium oxygen mixture on the adaptation of the organism to exercise. Acta Physiol Pol. 1984, 35 (3): 285-292.PubMedGoogle Scholar
  34. Pagel PS, Krolikowski JG: Transient Metabolic Alkalosis during early reperfusion abolishes helium preconditioning against myocardial infarction: restoration of cardioprotection by cyclosporin A in rabbits. Anesth Analg. 2009, 108 (4): 1072-1082.View ArticleGoogle Scholar
  35. Pagel PS, Krolikowski JG, Pratt PF, Shim YH, Amour J, Warltier DC, Weihrauch D: Reactive oxygen species and mitochondrial adenosine triphosphate-regulated potassium channels mediate helium-induced preconditioning against myocardial infarction in vivo. J Cardiothorac Vasc Anesth. 2008, 22 (4): 554-559. 10.1053/j.jvca.2008.04.005.PubMed CentralPubMedView ArticleGoogle Scholar
  36. Pagel PS, Krolikowski JG, Pratt PF, Shim YH, Amour J, Warltier DC, Weihrauch D: The mechanism of helium-induced preconditioning: a direct role for nitric oxide in rabbits. Anesth Analg. 2008, 107 (3): 762-768. 10.1213/ane.0b013e3181815995.PubMed CentralPubMedView ArticleGoogle Scholar
  37. Pagel PS, Krolikowski JG, Pratt PF, Shim YH, Amour J, Warltier DC, Weihrauch D: Inhibition of glycogen synthase kinase or the apoptotic protein p53 lowers the threshold of helium cardioprotection in vivo: the role of mitochondrial permeability transition. Anesth Analg. 2008, 107 (3): 769-775. 10.1213/ane.0b013e3181815b84.PubMed CentralPubMedView ArticleGoogle Scholar
  38. Pagel PS, Krolikowski JG, Amour J, Warltier DC, Weihrauch D: Morphine reduces the threshold of helium preconditioning against myocardial infarction: the role of opioid receptors in rabbits. J Cardiothorac Vasc Anesth. 2009, 23 (5): 619-624. 10.1053/j.jvca.2008.12.020.PubMed CentralPubMedView ArticleGoogle Scholar
  39. Heinen A, Huhn R, Smeele KM, Zuurbier CJ, Schlack W, Preckel B, Weber NC, Hollmann MW: Helium induced preconditioning in young and old rat heart: impact of mitochondrial Ca2+−sensitive potassium channel activation. Anesthesiology. 2008, 109 (5): 830-836. 10.1097/ALN.0b013e3181895aa0.PubMedView ArticleGoogle Scholar
  40. Oei GT, Huhn R, Heinen A, Hollmann MW, Schlack WS, Preckel B, Weber NC: Helium-induced cardioprotection of healthy and hypertensive rat myocardium in vivo. Eur J Pharmacol. 2012, 684 (1–3): 125-131.PubMedView ArticleGoogle Scholar
  41. Miller KW, Paton WD, Streett WB, Smith EB: Animals at very high pressures of helium and neon. Science. 1967, 157: 97-98. 10.1126/science.157.3784.97.PubMedView ArticleGoogle Scholar
  42. Lever MJ, Miller KW, Paton WDM, Streett WB, Smith EB: Effects of hydrostatic pressure on mammals. Proceedings of the IVth Symposium on Underwater Physiology. Edited by: Lambertsen CJ. 1971, New York: Academic, 101-108.View ArticleGoogle Scholar
  43. Happer W, Miron E, Schaefer S, Schreiber D, van Wijngaarden WA, Zeng X: Polarization of nuclear spins of noble-gas atoms by spin exchange with optically pumped alkali-metal atoms. Phys. Rev. A. 1984, 29: 3092-3110. 10.1103/PhysRevA.29.3092.View ArticleGoogle Scholar
  44. Pan Y, Zhang H, VanDeripe DR, Cruz-Flores S, Panneton WM: Heliox and oxygen reduce infarct volume in a rat model of focal ischemia. Exp Neurol. 2007, 205 (2): 587-590. 10.1016/j.expneurol.2007.03.023.PubMedView ArticleGoogle Scholar
  45. Coburn M, Maze M, Franks NP: The neuroprotective effects of xenon and helium in an in vitro model of traumatic brain injury. Crit Care Med. 2008, 36 (2): 588-595. 10.1097/01.CCM.0B013E3181611F8A6.PubMedView ArticleGoogle Scholar
  46. Jawad N, Rizvi M, Gu J, Adeyi O, Tao G, Maze M, Ma D: Neuroprotection (and lack of neuroprotection) afforded by a series of noble gases in an in vitro model of neuronal injury. Neurosci Lett. 2009, 460 (3): 232-236. 10.1016/j.neulet.2009.05.069.PubMedView ArticleGoogle Scholar
  47. Rizvi M, Jawad N, Li Y, Vizcaychipi MP, Maze M, Ma D: Effect of Noble Gases on oxygen and glucose deprived injury in human tubular kidney cells. Exp Biol Med (Maywood). 2010, 235 (7): 886-891. 10.1258/ebm.2010.009366.View ArticleGoogle Scholar
  48. Robert D, Franks NP: Bench to Bedside Review: Molecular Pharmacology and clinical use of inert gases in anesthesia and neuroprotection. Critic Care. 2010, 14 (4): 229-10.1186/cc9051.View ArticleGoogle Scholar
  49. Van Breugel HH, Bar PR: He-Ne laser irradiation affects proliferation of cultured rat Schwann cells in a dose-dependent manner. J Neurocytol. 1993, 22 (3): 185-190. 10.1007/BF01246357.PubMedView ArticleGoogle Scholar
  50. Brackman MR, Finelli FC, Light T, Llorente O, McGill K, Kirkpatrick J: Helium pneumoperitoneum ameliorates hypercarbia and acidosis associated with carbon dioxide insufflation during laparoscopic gastric bypass in pigs. Obes Surg. 2003, 13 (5): 768-771. 10.1381/096089203322509363.PubMedView ArticleGoogle Scholar
  51. Cheng Y, Lu J, Xiong X, Wu S, Lin Y, Wu T, Cheng N: Gases for establishing pneumoperitoneum during laparoscopic abdominal surgery. Cochrane Database Syst Rev. 2013, Art. No (1): CD009569-10.1002/14651858.CD009569.pub2.Google Scholar
  52. Makarov DV, Daraspreet K, Link RE, Kavoussi LR: Physiologic Changes During Helium Insufflation in High-Risk Patients During Laparoscopic Renal Procedures. Urology. 2007, 70 (1): 35-37. 10.1016/j.urology.2007.03.010.PubMedView ArticleGoogle Scholar
  53. Naude GP, Bongard FS: Helium Insufflation in Laparoscopic Surgery. Endosc Surg Allied Technology. 1995, 3 (4): 183-186.Google Scholar
  54. Waseda M, Murakami M, Kato T, Kusamo M: Helium Gas Pneumoperitoneum Can Improve the Recovery of Gastrointestinal Motility After a Laparoscopic Operation. Minim Invasive Ther Allied Technology. 2005, 14 (1): 14-18. 10.1080/13645700510010782.View ArticleGoogle Scholar
  55. Vargo JJ: Clinical applications of argon plasma coagulator. Gastrointest Endosc. 2004, 59: 81-88. 10.1016/S0016-5107(03)02296-X.PubMedView ArticleGoogle Scholar
  56. Magnetic Resonance Imaging: Review of Current and Emerging Translational Methods and Applications. J Magn Reson Imaging. 2010, 32: 1398-1408. 10.1002/jmri.22375.View ArticleGoogle Scholar
  57. Bouchiat M, Carver T, Varnum C: Nuclear polarization in 3He gas induced by optical pumping and dipolar exchange. Phys Rev Lett. 1960, 5: 373-375. 10.1103/PhysRevLett.5.373.View ArticleGoogle Scholar
  58. Frazier MD, Cheifetz IM: The Role of Heliox in Paediatric Respiratory Disease. Paediatr Respir Rev. 2010, 11 (1): 46-53. 10.1016/j.prrv.2009.10.008.PubMedView ArticleGoogle Scholar
  59. Walker TG, Happer W: Spin-exchange optical pumping of noble gas nuclei. Rev Mod Phys. 1997, 69: 629-642. 10.1103/RevModPhys.69.629.View ArticleGoogle Scholar
  60. Albert MS, Cates GD, Driehuys B, et al: Biological magnetic resonance imaging using laser-polarized 129Xe. Nature. 1994, 370: 199-201. 10.1038/370199a0.PubMedView ArticleGoogle Scholar
  61. Middleton H, Black RD, Saam B, et al: MR imaging with hyperpolarized 3He gas. Magn Reson Med. 1995, 33: 271-275. 10.1002/mrm.1910330219.PubMedView ArticleGoogle Scholar
  62. MacFall JR, Charles HC, Black RD, et al: Human lung air spaces: potential for MR imaging with hyperpolarized He-3. Radiology. 1996, 200: 553-558.PubMedView ArticleGoogle Scholar
  63. De Lange EE, Altes TA, Patrie JT, et al: The variability of regional airflow obstruction within the lungs of patients with asthma: assessment with hyperpolarized helium-3 magnetic resonance imaging. J Allergy Clin Immunol. 2007, 119: 1072-1078. 10.1016/j.jaci.2006.12.659.PubMedView ArticleGoogle Scholar
  64. De Lange EE, Altes TA, Patrie JT, et al: Changes in regional airflow obstruction over time in the lungs of patients with asthma: evaluation with 3He MR imaging. Radiology. 2009, 250: 567-575. 10.1148/radiol.2502080188.PubMedView ArticleGoogle Scholar
  65. Tzeng YS, Lutchen K, Albert M: The difference in ventilation heterogeneity between asthmatic and healthy subjects quantified using hyperpolarized 3He MRI. J Appl Physiol. 2009, 106: 813-822. 10.1152/japplphysiol.01133.2007.PubMedView ArticleGoogle Scholar
  66. Altes TA, de Lange EE: Applications of hyperpolarized helium-3 gas magnetic resonance imaging in pediatric lung disease. Top Magn Reson Imaging. 2003, 14: 231-236. 10.1097/00002142-200306000-00003.PubMedView ArticleGoogle Scholar
  67. Rice WL, Van Hoek AN, Păunescu TG, Huynh C, Goetze B, et al: High Resolution Helium Ion Scanning Microscopy of the Rat Kidney. PLoS One. 2013, 8 (3): e57051-10.1371/journal.pone.0057051.PubMed CentralPubMedView ArticleGoogle Scholar

Copyright

© Berganza and Zhang; licensee BioMed Central Ltd. 2013

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.